Inogen (INGN) News Today $10.47 -0.05 (-0.48%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$10.12 -0.36 (-3.39%) As of 08:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in DecemberInogen, Inc. (NASDAQ:INGN - Get Free Report) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 714,200 shares, a drop of 6.2% from the December 15th total of 761,300 shares. Based on an average trading volume of 187,000 shares, the days-to-cover ratio is presently 3.8 days.January 19 at 1:21 PM | marketbeat.comCautious Hold Rating on Inogen Amid Mixed Growth Signals and Business ChallengesJanuary 14, 2025 | markets.businessinsider.comInogen (NASDAQ:INGN) Given "Hold" Rating at Needham & Company LLCNeedham & Company LLC reiterated a "hold" rating on shares of Inogen in a research report on Tuesday.January 14, 2025 | marketbeat.comInogen reports preliminary Q4 revenue $79M, consensus $73.9MJanuary 14, 2025 | markets.businessinsider.comInogen’s Q4 Revenue Beat Overshadowed by Lack of Guidance, Earning a Hold RatingJanuary 14, 2025 | markets.businessinsider.comInogen Announces Preliminary Fourth Quarter and Full Year 2024 RevenueJanuary 14, 2025 | finance.yahoo.comInogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving Average - Here's WhyInogen (NASDAQ:INGN) Stock Price Crosses Above 50 Day Moving Average - Time to Sell?January 14, 2025 | marketbeat.comJane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN)Jane Street Group LLC lowered its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 83.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 50,927 shares of the medical technology company's stock after selling 250,473 shares duJanuary 6, 2025 | marketbeat.comInogen Expands U.S. Market with FDA ClearanceDecember 31, 2024 | markets.businessinsider.comInogen gets FDA 510(k) clearance for the SIMEOX 200 Airway Clearance DeviceDecember 31, 2024 | markets.businessinsider.comInogen Gets FDA Clearance for Airway Clearance DeviceDecember 30, 2024 | marketwatch.comInogen Secures FDA 510(k) Clearance For SIMEOX 200 Airway Clearance DeviceDecember 30, 2024 | markets.businessinsider.comInogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance DeviceDecember 30, 2024 | businesswire.comInogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78%December 21, 2024 | finance.yahoo.comStockNews.com Downgrades Inogen (NASDAQ:INGN) to HoldStockNews.com lowered Inogen from a "buy" rating to a "hold" rating in a report on Friday.December 20, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Sees Significant Growth in Short InterestInogen, Inc. (NASDAQ:INGN - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 794,700 shares, an increase of 6.7% from the November 15th total of 744,800 shares. Based on an average daily trading volume, of 192,900 shares, the short-interest ratio is currently 4.1 days.December 17, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Holdings Raised by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 312.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 174,625 shares of the medical technNovember 26, 2024 | marketbeat.comBrown Capital Management LLC Lowers Position in Inogen, Inc. (NASDAQ:INGN)Brown Capital Management LLC reduced its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 20.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,558,458 shares of the medical technology company's stock after selling 392,478 shares during the perNovember 21, 2024 | marketbeat.comShort Interest in Inogen, Inc. (NASDAQ:INGN) Declines By 11.4%Inogen, Inc. (NASDAQ:INGN - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 826,300 shares, a decline of 11.4% from the October 15th total of 932,600 shares. Based on an average daily volume of 190,100 shares, the days-to-cover ratio is currently 4.3 days.November 17, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comUS$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These ResultsNovember 10, 2024 | uk.finance.yahoo.comInogen, Inc. (INGN) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comInogen, Inc. Reports Third Quarter 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comNeedham Keeps Their Hold Rating on Inogen (INGN)November 9, 2024 | markets.businessinsider.comInogen, Inc. (INGN): A Bear Case TheoryNovember 8, 2024 | msn.comInogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC ChallengesNovember 8, 2024 | finance.yahoo.comInogen (NASDAQ:INGN) Earns "Hold" Rating from Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Inogen in a research report on Friday.November 8, 2024 | marketbeat.comInogen Inc (INGN) Q3 2024 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comInogen to Present at Upcoming Investor ConferencesNovember 6, 2024 | finance.yahoo.comInogen (INGN) Set to Announce Quarterly Earnings on ThursdayInogen (NASDAQ:INGN) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636745)October 31, 2024 | marketbeat.comInogen (NASDAQ:INGN) Stock Passes Below 200 Day Moving Average - Here's WhyInogen (NASDAQ:INGN) Stock Price Passes Below 200 Day Moving Average - Should You Sell?October 23, 2024 | marketbeat.comSanctuary Advisors LLC Acquires Shares of 80,075 Inogen, Inc. (NASDAQ:INGN)Sanctuary Advisors LLC bought a new position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 80,075 shares of the medical technologyOctober 15, 2024 | marketbeat.comInogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC ChallengesOctober 9, 2024 | finance.yahoo.comInogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POCOctober 8, 2024 | finance.yahoo.comMarshall Wace LLP Cuts Stock Holdings in Inogen, Inc. (NASDAQ:INGN)Marshall Wace LLP decreased its position in Inogen, Inc. (NASDAQ:INGN - Free Report) by 62.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 125,205 shares of the medical technology company's stock after selOctober 8, 2024 | marketbeat.comB. Riley Wealth Advisors Inc. Buys Shares of 56,200 Inogen, Inc. (NASDAQ:INGN)B. Riley Wealth Advisors Inc. bought a new position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 56,200 shares of the medical technology company'October 7, 2024 | marketbeat.comAQR Capital Management LLC Raises Stock Holdings in Inogen, Inc. (NASDAQ:INGN)AQR Capital Management LLC boosted its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 29.3% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 570,994 shares of the medical technology company's stock after buyiOctober 6, 2024 | marketbeat.comInogen (NASDAQ:INGN) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comInogen: Upside Seems Limited After Big Move UpSeptember 24, 2024 | seekingalpha.comInogen, Inc. (NASDAQ:INGN) Position Increased by Divisadero Street Capital Management LPDivisadero Street Capital Management LP increased its holdings in Inogen, Inc. (NASDAQ:INGN - Free Report) by 682.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,346,766 shares of the medical technology company's stSeptember 20, 2024 | marketbeat.comMonaco Asset Management SAM Purchases New Holdings in Inogen, Inc. (NASDAQ:INGN)Monaco Asset Management SAM purchased a new stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 75,000 shares of the medical technology company's stock, valued atSeptember 10, 2024 | marketbeat.comInogen Appoints Eric Pauls as Vice President of Sales, North AmericaSeptember 6, 2024 | finance.yahoo.comInogen, Inc. (NASDAQ:INGN) Sees Large Decline in Short InterestInogen, Inc. (NASDAQ:INGN - Get Free Report) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,350,000 shares, a decline of 8.2% from the July 15th total of 1,470,000 shares. Based on an average daily trading volume, of 224,000 shares, the short-interest ratio is presently 6.0 days.August 18, 2024 | marketbeat.comVanguard Group Inc. Increases Position in Inogen, Inc. (NASDAQ:INGN)Vanguard Group Inc. boosted its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 4.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,424,026 shares of the mediAugust 14, 2024 | marketbeat.comInogen (NASDAQ:INGN) Upgraded to Hold at StockNews.comStockNews.com raised Inogen from a "sell" rating to a "hold" rating in a research note on Tuesday.August 13, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Analysts Are Pretty Bullish On The Stock After Recent ResultsAugust 10, 2024 | finance.yahoo.comInogen (NASDAQ:INGN) Issues Earnings Results, Beats Expectations By $0.31 EPSInogen (NASDAQ:INGN - Get Free Report) announced its earnings results on Tuesday. The medical technology company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.55) by $0.31. Inogen had a negative return on equity of 42.87% and a negative net margin of 30.07%. The company had revenue of $88.77 million for the quarter, compared to analyst estimates of $82.50 million. During the same quarter last year, the company earned ($0.42) earnings per share. The firm's quarterly revenue was up 6.1% compared to the same quarter last year.August 9, 2024 | marketbeat.comInogen Shares Rally Premarket After 2Q Results Top ViewsAugust 7, 2024 | marketwatch.comInogen, Inc. (NASDAQ:INGN) Q2 2024 Earnings Call TranscriptAugust 7, 2024 | insidermonkey.comInogen's (INGN) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Inogen in a report on Wednesday.August 7, 2024 | marketbeat.com Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address INGN Media Mentions By Week INGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INGN News Sentiment▼0.350.49▲Average Medical News Sentiment INGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INGN Articles This Week▼22▲INGN Articles Average Week Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Establishment Labs News Paragon 28 News National Vision News Bioventus News AxoGen News Butterfly Network News CeriBell News Iradimed News Avanos Medical News SI-BONE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INGN) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.